Hypomethylation/high expression of NTRK2, a druggable tyrosine receptor kinase56 playing a role in the reciprocal signalling between GIC and their differentiated glioblastoma cell progeny55, predicts response to the specific inhibitor cyclotraxin-B. This evidence concerns the gene NTRK2 and glioblastoma.